Oscar Health, Inc.

OSCR Healthcare Healthcare Plans

Oscar Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $11.7 billion, up 27.5% from fiscal 2024. In the quarter to June 2026, revenue grew 70.4%, EPS grew 234.8%, free cash flow grew 316.3% and total debt rose 43.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

33.79 0.22 −0.65%
Market cap
$10.5B
P/E
19.8×
Fwd P/E
29.7×
Dividend yield
—
F-score
3/9
Altman Z
1.07
Beneish M
−2.18
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
16.68 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.56 0.26 0.32 0.43
P/FCF ratio
1.97 1.22 3.56 6.67
P/Operating CF
4.12 1.31 5.61 (5.09)
P/B ratio
4.19 2.05 3.84 4.78
EV/Sales
0.32 (0.07) 0.12 0.31
EV/EBITDA
7.87 0.00 0.00 0.00
EV/FCF
1.14 (0.34) 1.35 4.68
Current Ratio
0.57 0.83 0.72 0.69
Net Debt/EBITDA
(9.40) (6.20) 7.07 11.34
Debt/Equity
0.21 0.26 0.44 0.67
Earnings Yield
6.00% (3.31%) (10.86%) (4.97%)
Free Cash Flow Yield
50.82% 81.84% 28.07% 14.99%
Free Cash Flow per Share
6.88 8.75 2.53 (3.76)
Book value per Share
6.80 5.59 3.74 3.96
Free Cash Flow
2,080.58 2,610.19 662.84 (973.66)
EV/EBIT
7.90 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates